On Invalid Date, Bruker (NASDAQ: BRKR) reported Q2 2022 earnings per share (EPS) of $0.33, up 13.16% year over year. Total Bruker earnings for the quarter were $49.50 million. In the same quarter last year, Bruker's earnings per share (EPS) was $0.38.
As of Q3 2022, Bruker's earnings has grown 17.42% year over year. This is 0.4 percentage points lower than the US Medical Devices industry earnings growth rate of 17.82%. Bruker's earnings in the past year totalled $273.90 million.
On Invalid Date, Bruker (NASDAQ: BRKR) reported Q2 2022 revenue of $588.40 million up 3.08% year over year. In the same quarter last year, Bruker's revenue was $570.80 million.
What was BRKR's revenue growth in the past year?
As of Q3 2022, Bruker's revenue has grown 9.34% year over year. This is 4 percentage points lower than the US Medical Devices industry revenue growth rate of 13.34%. Bruker's revenue in the past year totalled $2.48 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.